INTRODUCTION
============

Leptospirosis is a re-emerging infectious zoonotic disease that occurs in tropical and subtropical regions.^[@bib1],[@bib2],[@bib3]^ In Taiwan, a major outbreak occurred in 2009 after typhoon Morakot, with 203 confirmed cases of leptospirosis.^[@bib4]^ Leptospirosis, as caused by leptospires, is characterized by fever, jaundice, renal failure and/or pulmonary hemorrhage culminating in multiple-organ dysfunction. Pathogenic *Leptospira* species are transmitted to humans after contact with animal reservoirs or through environmental contamination with their urine.^[@bib5],[@bib6]^ Kidney injury is an early manifestation of acute leptospirosis, occurring within days of infection, and kidney damage occurs late in chronic infections.^[@bib7]^ Tubulointerstitial nephritis presents either in an acute or chronic form, and it is the primary cause of renal injury in leptospirosis. Leptospirosis is a common cause of acute tubulointerstitial nephritis that may cause acute kidney injury, and it has the propensity to damage blood vessels and the kidney structure.^[@bib8]^ During leptospiral chronic infection, tubulointerstitial nephritis is the most common lesion that can progress to fibrosis and subsequent renal failure. In kidneys, the leptospires chronically infect and harbor the bacteria in renal tubules.^[@bib7]^ The mechanisms of *Leptospira* kidney pathogenesis remain unclear, and the virulent factors of *Leptospira* need further identification.

*Leptospira* species belonging to multi-chromosomal genomes consist of a genetically diverse group of pathogenic, intermediate pathogenic and saprophytic species.^[@bib9],[@bib10]^ *L. interrogans* contains a large number of serogroups, the strains of which are pathogenic for humans and animals, whereas *L. bijlexa* also contains a large number of serogroups, which are saprophytic species primarily found in fresh surface water and moist soil. Whole-genome sequences of *Leptospira* species are being completed, allowing for a comparative genomic analysis of the adaptation of different species to their natural habitats and pathogenesis.^[@bib11]^ To date, the whole-genome analysis of *Leptospira* species has provided insights into their pathogenesis, and genome sequencing efforts have so far focused on pathogenic (*L. interrogans* and *L. borgpetersenii*) and saprophytic species (*L. biflexa*).^[@bib12],[@bib13],[@bib14],[@bib15],[@bib16],[@bib17],[@bib18]^ The genome sequence of *L. interrogans* serovar Lai was published, and a comparative genomic analysis with *L. interrogans* serovar Copenhageni has been performed.^[@bib19]^ Our team has sequenced a draft genome of *L. santarosai* serovar Shermani, the highest prevalent serovar in Taiwan, by using high-throughput Illumina sequencing platforms.^[@bib20]^ The genome sequence of *L. santarosai* serovar Shermani has been deposited at DDBJ/EMBL/GenBank under the accession number ADOR00000000. However, a comparative genetic analysis based on BLASTx data revealed that only 73% of all coding sequences (CDS) include matches with pathogenic *L. interrogans*. These results suggested that *L. interrogans* and *L. santarosai* serovar Shermani might have different pathogenesis mechanisms. A recent report by Wilson *et al.*^[@bib21]^ indicated that the application of genome sequences may aid in the clinical diagnosis of neuroleptospirosis by *L. santarosai*; hence, the effort required to obtain the complete genome sequence is justified.

Several virulent factors in pathogenic *Leptospira* species have been identified, including lipopolysaccharide, lipoproteins, outer membrane proteins (OMPs) and cell wall components, which are functionally and structurally important for nutritional uptake, signal transduction, cell stabilization, and immunogenicity.^[@bib22],[@bib23]^ Our previous finding indicates that a major OMP, namely LipL32 from *L. santarosai* serovar Shermani, can induce the secretion of inflammatory cytokines in murine renal tubular cells via a Toll-like receptor-dependent pathway and cause tubulointerstitial nephritis in mice.^[@bib24],[@bib25],[@bib26],[@bib27]^ The major antigens of pathogenic *Leptospira* are lipopolysaccharide and lipoproteins, which are pathogen-associated molecular patterns found in the kidneys of *Leptospira*-infected animals, and they link to *Leptospira*-induced tubular interstitial nephritis.^[@bib28]^ Pathogenic leptospires have been shown to express OMPs and many lipoproteins, suggesting that they could play a role in kidney--pathogen interactions.

In this study, we described a method to assemble the complete genome sequence of *L. santarosai* serovar Shermani strain LT821 *de novo* by integrating second- and third- generation sequencing methods with optical whole-genome mapping. Here, we report the genome sequence of *L. santarosai* serovar Shermani strain LT821, a less-characterized bacterium in the genus *Leptospira* that has been linked to leptospirosis. The draft genome sequence consists of 111 contigs with a total determined size of 3 936 333 base pairs (bp) and 4033 predicted genes, and the majority of these non-orthologous genes encode hypothetical proteins.^[@bib20]^

To understand what characteristics differentiate these *Leptospira* species, particularly in terms of virulence capacity, we report the first genome sequence of *L. santarosai* and then perform a comparative genomic analysis between the whole-genome sequence and the recently described genome sequence of *Leptospira* species. In addition, *L. santarosai* serovar Shermani strain CCF, which was isolated from a Taiwanese patient with leptospirosis in 2001,^[@bib29]^ was analyzed for its gene sequences. Furthermore, comparative analyses of differential leptospiral gene expressions in *L. santarosai* serovar Shermani and *L. interrogans* serovar Copenhageni that infected human kidney 2 (HK-2) cells, which are human renal proximal tubular cells, were performed in this study. An analysis of leptospiral gene expression in cell-based infection models are vital for identifying differentially regulated genes that are relevant to pathogenesis.

The new features of the *L. santarosai* serovar Shermani found in this study may contribute to our understanding of the molecular mechanisms of leptospiral physiology and pathogenesis. The comparative genomic characteristics of this subset of human pathogens may contribute to our understanding of how they adapt to environments and acquire increased virulence.

MATERIALS AND METHODS
=====================

Bacterial strains, cell and culture conditions
----------------------------------------------

*L. santarosai* serovar Shermani strain LT821 (ATCC number 43286) and *L. interrogans* serovar Copenhageni Fiocruz L1-130 (ATCC number BAA-1198) were purchased from the American Type Culture Collection (Manassas, VA, USA). A clinical *L. santarosai* serovar Shermani strain CCF was isolated from a Taiwanese patient with leptospirosis in 2010.^[@bib29]^ The bacteria were propagated at 28 °C under aerobic conditions in medium containing 10% *Leptospira* enrichment Ellinghausen--McCullough--Johnson--Harris medium (BD Diagnostics, Sparks, MD, USA) and 90% *Leptospira* medium base Ellinghausen--McCullough--Johnson--Harris (Difco, Sparks, MD, USA). Bacterial densities were counted with a CASY-Model TT cell counter and analyzer (Roche Innovatis AG, Casy-Technologh, Reutlingen, Germany). *Leptospira* genomic DNA was extracted from seven-day-old cultures by using a procedure similar to the cetyltrimethylammonium bromide precipitation method.^[@bib30]^ HK-2, the immortalized human renal proximal tubular cell line, was obtained from ATCC (number CRL-2190; Maryland, USA) and cultured in DMEM/Ham\'s F12 (Life Technologies, Paisley, UK) supplemented with 10% fetal calf serum (Biological Industries Ltd, Cumbernauld, UK), glutamine (Life Technologies, Paisley, UK), HEPES buffer (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; Gibco BRL, Paisley, UK), hydrocortisone, insulin, transferrin and sodium selenite (Sigma Chemical Company Ltd, Poole, UK). Cells were grown at 37 °C under a humidified atmosphere with 5% CO~2~. All experiments are performed under serum-free conditions to avoid the influence of serum on cell function and the investigated events.

Genome sequencing, assembly and annotation
------------------------------------------

The genomic DNA of *L. santarosai* serovar Shermani strain LT821 was subjected to high-throughput sequencing by using the next-generation sequencer: Illumina (Solexa) Genome Analyzer II DNA sequencer (Illumina Inc., San Diego, CA, USA), a 454 GS FLX platform (Roche, Branford, USA) and a Pacific Biosciences RS sequencer (the PacBio; Pacific Biosciences, Menlo Park, USA). The *de novo* assembly was performed by using Velvet, a hierarchical genome-assembly process (HGAP; Pacific Biosciences, Menlo Park, California, USA), A Hybrid Assembler (AHA; Pacific Biosciences, Menlo Park, California, USA) and the *de novo* assembler from CLC bio, a QIAGEN Company.^[@bib31],[@bib32],[@bib33]^ The order and orientation of these contigs were confirmed by optical mapping systems (OpGen Technologies Inc., Madison, WI, USA).^[@bib34]^ In brief, a whole-genome AflII map was constructed from randomly sheared *L. santarosai* serovar Shermani genomic DNA molecules digested with AflII. The map acted as a scaffold for the high-resolution whole-genome map was aligned with sequence contigs with MapManager software (OpGen Technologies Inc., Madison, WI, USA). The gap closure and validation of assembly sequences were achieved by polymerase chain reaction (PCR) and Sanger sequencing of the amplicons. We designed a subset of primer pairs that were located at a minimum distance of 50 bp upstream and downstream from the gaps and neighboring contig/scaffold ends. The genomic DNA of *L. santarosai* serovar Shermani was used as a template in the PCR reaction with an AccuPrime Taq DNA polymerase High Fidelity Kit (Invitrogen, Carlsbad, CA, USA) according to the following program: 95 °C for 1 min, then 35 cycles of 95 °C for 30 s, 65 °C for 30 s, 72 °C for 3 min followed by a final extension at 72 °C for 10 min. The successfully amplified products that did not contain nonspecific amplification products were recovered and purified by using a Gel/PCR DNA Fragments Extraction Kit (Geneaid Biotech Ltd., Taipei, Taiwan) and further studied by the DNA Sequencing Core Laboratory (Chang Gung Memorial Hospital, Linkou, Taiwan) by using Sanger sequencing in both forward and reverse directions. Assembly sequences were concatenated with CLC Genomics Workbench 5.1 (CLC Bio, Aarhus, Denmark) with default parameters. The finished assembled sequences were annotated from the Prokaryotic Genomes Automatic Annotation Pipeline (<http://www.ncbi.nlm.nih.gov/genomes/static/Pipeline.html>). Graphical maps of circular genomes were generated from the Circular Genome Viewer (CGView) Server.^[@bib35],[@bib36]^

Comparative analysis
--------------------

A comparison of whole genomes from *L. santarosai* serovar Shermani and previously published pathogenic *Leptospira* spp. was performed by the MAUVE alignment system, the CGView Comparison Tool and BLASTp analysis.^[@bib37]^ Previously published *Leptospira* spp. sequences were downloaded from the NCBI and the accession numbers of the genome sequences are listed in [Table 1](#tbl1){ref-type="table"}. Functional domains of putative proteins were identified by searching against the Pfam database.^[@bib38]^

Nucleotide sequence accession number
------------------------------------

The complete genome sequence of *L. santarosai* serovar Shermani strain LT821 (ATCC number 43286) has been deposited at DDBJ/EMBL/GenBank under the accession number CP006694 for chromosome I and at CP006695 for chromosome II.

The PCR-based identification of specific genes in a clinical *L. santarosai* serovar Shermani isolate from a patient with *Leptospirosis*
-----------------------------------------------------------------------------------------------------------------------------------------

A PCR using primers designed from a *L. santarosai* serovar Shermani DNA sequence was used to investigate the presence of these genes in a clinical *L. santarosai* serovar Shermani strain CCF isolate from a Taiwanese patient with leptospirosis.^[@bib29]^ The primer sequences are listed in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}. *Leptospira* genomic DNA (500 ng) was used as starting material. Standard Taq polymerase (1.25 units), 200 μM of each deoxynucleotide triphosphate and 0.5 μM primers were used. The amplification was performed in a PTC-100 Programmable Thermal Controller (M. J. Research Inc., Waltham, Massachusetts, USA) under the following conditions: 95 °C for 1 min for one cycle, 35 cycles of 95 °C for 30 s, 65 °C for 30 s and 72 °C for 3 min, followed by a final extension at 72 °C for 10 min. The PCR products were separated on 1% agarose gels containing 0.05% ethidium bromide and visualized under ultraviolet light, sized and photographed (ChemiDoc XRS system; Bio-Rad, Hercules, CA, USA). The amplification products were recovered and purified with a Gel/PCR DNA Fragments Extraction Kit (Geneaid Biotech. Ltd) and the sequencing of the resulting PCR products was performed by the DNA Sequencing Core Laboratory (Chang Gung Memorial Hospital, Linkou, Taiwan).

Cell-based infection models for leptospiral gene expression analysis
--------------------------------------------------------------------

The cultured HK-2 cells were grown to 80%--90% confluence in fresh media without antibiotics and serum, and they were cultured for an additional 12 h before infection. *Leptospira* cells were harvested by centrifugation at 4000*g* for 15 min. The HK-2 cells in each sample were incubated in suspension with either *L. santarosai* serovar Shermani strain LT821 or *L. interrogans* serovar Copenhageni Fiocruz L1-130, or without any bacteria, for 4 h at 37 °C in 5% CO~2~. The multiplicity of infection was 100 bacteria per cell. After incubation, the cells were washed with PBS and harvested for RNA isolation. Each sample was lysed in 1 mL of RNA-Bee RNAzol reagent (Tel-Test Inc., Friendswood, TX, USA) with a DNaseI digestion according to the manufacturer\'s instructions. The total RNA concentrations were determined with a NanoDrop ND-1000 Spectrophotometer (Thermo Scientific, Wilmington, DE, USA). DNase-treated RNA (∼1 μg per sample) was reverse-transcribed with a First Strand cDNA Synthesis Kit for reverse transcription PCR (RT-PCR) (AMV) (Roche Diagnostics, Mannheim, Germany) with random primer p(dN)6s, dNTPs, 10x reaction buffer, MgCl~2~, RNase inhibitor and AMV reverse transcriptase. Quantitative real-time RT-PCR assays with SYBR Green PCR Master Mix (PE-Applied Biosystems, Cheshire, UK) were performed by using ABI ViiA7 real-time PCR systems (Applied Biosystems, Foster, CA, USA) for 50 cycles (95 °C 10 s, 60 °C 1 min and 60 °C 1 min). A dissociation curve step was added to ensure the optimization of the primers. For each primer pair described in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}, no-template control reactions were employed and each reaction was performed in triplicate. The threshold cycle number (*C*~T~) was determined by using PE-Applied Biosystems software. The relative transcript expression was calculated by using the 2^−ΔΔ*C~T~*^ method.^[@bib39]^ Fold changes in the gene expression in comparison with the control were determined and the error was determined by using the standard error of the mean.

Determining reference gene expression stability
-----------------------------------------------

To identify stable normalization genes for quantitative RT-PCR assays in each experimental set, the stability of the mRNA expression of each gene was statistically analyzed by using the following reference gene stability analysis software packages: the NormFinder algorithm and the BestKeeper Excel-based tool.^[@bib40],[@bib41]^ *C~T~* values from the ABI ViiA7 real-time PCR system (Applied Biosystems) were converted into relative quantities and imported into the NormFinder Add-in according to the manufacturer\'s instructions, and the results were shown as the expression stability. Candidate reference genes with the lowest expression stability were considered to be most stable under tested experimental conditions by combining the results from the analysis conducted with the NormFinder and BestKeeper programs.^[@bib42],[@bib43]^

RESULTS
=======

The *de novo* assembly of *L. santarosai* serovar Shermani
----------------------------------------------------------

Here we present a hybrid approach ([Figure 1](#fig1){ref-type="fig"}) for high-quality, whole-genome assemblies as performed *de novo* for *L. santarosai* serovar Shermani by using second-generation sequencing technology, namely Illumina paired-ends, mate-paired technology and the 454 GS FLX platform, and third-generation sequencing technology, specifically Single Molecule, Real-Time (SMRT) DNA sequencing technology (PacBio RS). We also used high-resolution, whole-genome restriction endonuclease maps of *L. santarosai* serovar Shermani to confirm the correct placement of the sequence contigs that were generated during the finishing process. The genome sequence of *L. santarosai* serovar Shermani that was derived from the Illumina paired-end reads data had been previously deposited in DDBJ/EMBL/GenBank.^[@bib20]^ Previously generated assemblies using Short Oligonucleotide Analysis Package *de novo* are comprised of 111 contigs covering 98.81% of the genome and have an N50 value of 97.5 kilobase (kb). To complete the highly repetitive genome, we sequenced genomic DNA from *L. santarosai* serovar Shermani by using mate-paired sequencing in the Illumina platform, Roche 454 and PacBio RS sequencing technology.

There were three sets of reads used in the assembly approach as follows: (i) Illumina reads, including a Illumina paired-end 500 bp library that generated 7 987 144 reads with approximately 150-fold coverage of the estimated genome size and an Illumina mate-pair 3000 bp library that generated 27 550 738 reads with approximately 550-fold coverage, which were used in the initial sequence assembly to generate scaffolds; (ii) 454-FLX pyrosequencing reads with a total of 597 201 reads (60-fold coverage of the estimated genome size) with average read lengths equal to 410 bp were used for the gap closure of genome sequence assemblies; and (iii) the PacBio RS long-read sequencing platform was generated from a single ∼10-kb SMRT library, which yielded 40 203 continuous long reads with a typical average read length of 3514 bp, and it was used to bridge segments of repetitive regions to form scaffolds. The 10 kb continuous long read data were filtered by read quality (\>0.75), resulting in approximately a four-fold coverage of the estimated leptospiral genome size. The sequencing statistics for the *L. santarosai* serovar Shermani whole-genome mapped reads are given in [Table 2](#tbl2){ref-type="table"}.

By integrating Illumina paired-end and mate-pair reads with the whole-genome restriction endonuclease maps (AflII; 30-fold coverage) of *L. santarosai* serovar Shermani, these Illumina reads were assembled *de novo* by using the Velvet assembler, resulting in six scaffolds with a total size of 3 910 176 bp, and the order of six scaffolds was generated from the high-resolution AflII optical map. We also used Sanger sequencing reads for 131 gaps within and between these scaffolds, and 130 gaps containing 21 gaps with a size of \>1 kb were closed. These gaps were closed by direct PCR methods, and the scaffolds were joined together into the first assembly sequences over 3 947 535 bp in length, covering 99.09% of the genome. After filling and closing with unplaced contigs, there was a remaining gap in which the 28 kb fragment was missing relative to the AflII optical map, and hence we suggest that the region may have arisen as highly repeated sequences, or a region of the genome is simply not represented in the read set.

To complete the genome, genomic DNA from *L. santarosai* serovar Shermani was sequenced and used to generate 454-FLX pyrosequencing reads from 454-FLX pyrosequencing and SMRT sequencing platforms. We tried to assemble contigs from different combination of reads. We used CLC *de novo* assembly for Illumina and Roche 454 reads with default parameters, which give us 79 and 243 contigs ([Table 2](#tbl2){ref-type="table"}). These assembled contigs were further assembled with long reads from PacBio. We used two different *de novo* assembling packages, namely, HGAP and AHA from PacBio SMRT Portal v2.0. The HGAP algorithm generates 13 contigs by using reads from the SMRT sequencing platform only. When applying the AHA to both PacBio and the contigs assembled from Illumina and Roache 454, 66 and 41 contigs were generated, respectively. In addition, we combined *de novo* contigs generated from an assembly of Illumina and Roche 454 sequence data with contigs assembled from PacBio reads to yield the second assembly sequences, for two nearly finished contigs covering 99% of the genome. In addition, sequences from a gap of 28 kb in size between scaffolding boards were filled by using PacBio RS information.

By mapping the first and second assembly sequences, the genome of *L. santarosai* serovar Shermani was 100% completed with a total size 3 983 611 bp. To validate the quality of this assembly, all raw reads from second- and third-generation sequencing technology and all Sanger sequence reads were mapped onto the complete genome sequences of *L. santarosai* serovar Shermani. The *L. santarosai* serovar Shermani genome was finished without relying on a reference genome, and we addressed three assembly platforms and generated two genome assemblies. The final finished genome sequences were annotated from the Prokaryotic Genomes Automatic Annotation Pipeline (<http://www.ncbi.nlm.nih.gov/genomes/static/Pipeline.html>). The sequences have been deposited in GenBank under accession numbers CP006694 (chromosome I) and CP006695 (chromosome II).

Features of the *L. santarosai* serovar Shermani genome
-------------------------------------------------------

The *L. santarosai* serovar Shermani genome consists of two circular chromosomes for a total of 3 983 611 bp, with a large one of 3 659 905 bp (chromosome I; CI) and a small one of 323 706 bp (chromosome II; CII), as evidenced by pulsed-field gel electrophoresis analysis (data not shown). Circular representations of both chromosomes are depicted in [Figure 2](#fig2){ref-type="fig"}. Two chromosomes from *L. santarosai* serovar Shermani have an overall G+C content of 41.82% containing 4079 CDSs with an average length of 830 bp (the largest CDS being 7773 bp), corresponding to a protein-coding content of 92.5%, with 5 genes for ribosomal RNAs (rRNAs) and 37 genes for transfer RNAs ([Table 1](#tbl1){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"}). As previously described, the rRNA genes in *L. santarosai* serovar Shermani are not organized into operons, as in most other bacteria, but they are scattered over chromosome I.^[@bib44]^ *L. santarosai* serovar Shermani has one *rrf* gene, two *rrl* genes and two *rrs* genes coding for 5S, 23S and 16S rRNAs, respectively. When comparing the complete *rrs* (16S) sequences for *L. santarosai* serovar Shermani, *L. borgpetersenii* and *L. interrogans*, the shared identity among the sequences is 99% to 98%. The *rrf* (5S) sequence identity comparing *L. santarosai* and *L. borgpetersenii* is 100% and the *rrl* (23S) is 100%. Based on ribosomal genes, *L. santarosai* and *L. borgpetersenii* are closely related, as supported by the whole-genome comparison. In comparison with the previous annotation of the *L. santarosai* serovar Shermani draft genome by using reciprocal BLASTx searches, it appears that an increase of 198 genes containing two genes for membrane protein, one gene for type IV pilus, one gene for imelysin^[@bib45]^ and 182 mostly hypothetical structural genes were identified from the finished genome. Imelysin-like proteins involved in iron uptake are widely distributed in bacteria. In addition, functional annotations of the finished genome sequence for *L. santarosai* serovar Shermani yielded 2612 hits for the Clusters of Orthologous Groups database.^[@bib46]^ Based on the Clusters of Orthologous Group functional classification scheme, genes encoding proteins are involved in function category L (replication, recombination and repairs) and function category D (cell cycle control, cell division and chromosome partitioning) in *L. santarosai* serovar Shermani compared with *L. interrogans, L. borgpetersenii* and *L. biflexa*, which may likely contribute to *L. santarosai* for the adaptation of the selective pressures and evolutionary developments that allowed its survival in a wide variety of environments such as animal and aquatic environments.

The presence of a large number of mobile genetic elements and clustered regularly interspaced short palindromic repeats (CRISPRs) may be a typical characteristic associated with *Leptospira* species that have the genome plasticity required for survival both within mammalian hosts and aquatic environments.^[@bib47]^ The genome of *L. santarosai* serovar Shermani has 48 transposases and 5 CRISPR genes homology, indicating that the *L. santarosai* genomic architecture may have undergone complex genetic alterations and genetic reshuffling during its evolutionary history.

The genome of *L. santarosai* serovar Shermani was compared with those of previously published pathogenic *Leptospira* spp. by using a genome alignment with progressive MAUVE.^[@bib48]^ A comparison analysis revealed that 11 unique regions, each with sizes greater than 10 kb in size, were found in the complete genome of *L. santarosai* serovar Shermani and 7 of which were identified as possible genomic islands (GIs) by web-based IslandViewer software.^[@bib49]^ In addition, comparative genetic analysis based on reciprocal BLASTp searches revealed that 32 unique CDSs encoding for hypothetical proteins were within these GIs. The Pfam analysis of these unique hypothetical proteins in *L. santarosai* serovar Shermani indicates that the LSS19962 protein belongs to the peptidase C39-like family. The unique genes in GIs from the *L. santarosai* serovar Shermani whole genome that are larger than or equal to 150 bp in length are summarized in [Table 3](#tbl3){ref-type="table"}. Taken together, the whole-genome comparison maps were visualized with CGView Comparison Tool software as shown in [Figure 3](#fig3){ref-type="fig"}.

In considering genes that are common to *Leptospira* species, direct comparisons between the predicted CDSs of *L. santarosai* and previously sequenced *Leptospira* species genomes were performed by reciprocal BLASTx searches, and we did not consider predicted CDSs that were less than or equal to 150 bp in length that lacked significant homologs. The result revealed that approximately 126 genes with no hits or non-significant hits in previously sequenced *Leptospira* species genome are only present in *L. santarosai*. Of these non-orthologous genes that are unique to *L. santarosai* serovar Shermani, 124 genes were for hypothetical proteins, and three genes (LSS08219, LSS19048 and LSS21610) were for metallophosphoesterase, peptidase M15A and transposase IS3, respectively. To understand the function of these unique hypothetical proteins in *L. santarosai* serovar Shermani, a Pfam-based motif/domain analysis was performed as part of this study. Of the 124 unique hypothetical genes, 4 were predicted to be a group II intron, one was predicted to be a lipoprotein and LSS19962 encoded a protein belonging to a peptidase C39-like family. We identified genes that were unique to *L. santarosai* serovar Shermani in this study and further examined these species-specific genes for their role in the pathogenesis and clinical diagnosis benefits that should be conducted as necessary.

Analyzing the gene sequences of *L. santarosai* serovar Shermani strain CCF
---------------------------------------------------------------------------

To investigate sequence similarities between *L. santarosai* serovar Shermani strain LT821 and strain CCF, we examined the conservation of genes in an isolate of *L. santarosai* serovar Shermani genome and a sequence alignment analysis by using a VectorNTI tool.^[@bib50]^ *L. santarosai* serovar Shermani strain CCF, a clinically important leptospire that was confirmed by microscope agglutination test, was isolated from a Taiwanese patient with leptospirosis who had acute tubulointerstitial nephritis.^[@bib29]^ According to the information from whole-genome sequences of the *L. santarosai* serovar Shermani strain LT821, we selected 30 CDSs with 17 for hypothetical genes and seven for lipoprotein to elucidate the presence or absence of these genes in the *L. santarosai* serovar Shermani strain CCF genome sequences.

Of these hypothetical genes, nine genes (LSS19413, LSS22130, LSS16416, LSS16441, LSS23260, LSS20184, LSS05845, LSS19962 and LSS20521) were unique in *L. santarosai* serovar Shermani strain LT821 and four genes (LSS22130, LSS16416, LSS16441 and LSS19962) were located in predicated GI regions. The primers used for gene-specific amplification are shown in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}. PCR products were separated on agarose gels, and the migration of the corresponding products from *L. santarosai* serovar Shermani strain LT821 is shown to compare the PCR product from *L. santarosai* serovar Shermani strain CCF ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). The successfully amplified products were recovered by gel extraction and further verified by sequencing at the DNA Sequencing Core Laboratory (Chang Gung Memorial Hospital, Linkou, Taiwan). This analysis revealed the presence of these gene elements and the same size PCR products in each primer set between *L. santarosai* serovar Shermani strain LT821 and strain CCF. Under the standard concentration of genomic DNA (500 ng), PCR product results differed slightly in brightness as shown for LSS16416, LSS0621, LSS05845, LSS07729, LSS14677, LSS13644, LSS13769, LSS23260, LSS15341, LSS11940 and LSS12614, explaining the number of gene variations between *L. santarosai* serovar Shermani strain LT821 and strain CCF. In addition, sequence similarity analysis revealed that these PCR products from two different strains of *L. santarosai* serovar Shermani exhibited no differences, suggesting a strong identity within *L. santarosai* serovar Shermani. These data indicated that there is strong sequence conservation between *L. santarosai* serovar Shermani strain LT821 and strain CCF.

A comparative analysis of differential leptospiral gene expression for *L. santarosai* serovar Shermani- and *L. interrogans* serovar Copenhageni-infected HK-2 cells
---------------------------------------------------------------------------------------------------------------------------------------------------------------------

*L. santarosai* serovar Shermani is the most frequently isolated serovar, and it causes both renal and systemic infections in Taiwan. From a clinical presentation perspective, *L. santarosai* serovar Shermani causes tubulointerstitial nephritis similar to that of other strains that induce nephritis, for example *L. interrogans* serovar Copenhageni. Nevertheless, it is interesting to note that leptospiral morphological differences exist between *L. santarosai*- and *L. interrogans*-infected HK-2 cells. After 4 h of infection at an multiplicity of infection of 100, *L. interrogans* serovar Copenhageni had a typical spiral shape. However, *L. santarosai* serovar Shermani tended to aggregate in culture conditions that were observed by using immunohistochemistry (with a polyclonal anti-leptospiral LipL32 antibody) (data not shown). *L. santarosai* serovar Shermani had a morphologically distinct form in an infectious condition with HK-2 cells, suggesting differential gene expressions for *L. santarosai* serovar Shermani- and *L. interrogans* serovar Copenhageni-infected HK-2 cells. According to data collected from transcriptomic approaches (data not shown), 12 gene targets containing 5 for hypothetical genes, 4 for lipoproteins and 1 for motility were selected to analyze in this study ([Supplementary Table S1](#sup1){ref-type="supplementary-material"} and [Supplementary Table S2](#sup1){ref-type="supplementary-material"}). By using BLAST to find homologous genes between *L. santarosai* serovar Shermani and *L. interrogans* serovar Copenhageni genomes, the genes selected for this study are listed in [Table 4](#tbl4){ref-type="table"}. The co-cultivation of pathogenic *Leptospira* spp. with HK-2 cells was used as an infection model to study leptospiral gene expressions. After infecting with *L. santarosai* serovar Shermani and *L. interrogans* serovar Copenhageni for 4 h in the cell medium without antibiotics and then harvesting, the bacteria were subjected to RNA extraction, cDNA synthesis and quantitative RT-PCR analysis.

In our cell-based-infection model study, the 16S rRNA gene was not a suitable potential reference gene/housekeeping gene, as evidence by the threshold cycle value of the 16S rRNA gene detected in a sample harvested from HK-2 cells without any bacteria. A combination of Normfinder and BestKeeper analyses were used to choose the best housekeeping gene. These tested genes were analyzed for the most stable control gene with the lowest expression stability, as defined as an internal control that was considered to be most stable under the tested experimental conditions. The stability value was 0.135 for the best combination of two gene targets, namely, LSS16476 and LSS08624, the most stable genes under our experimental conditions in which the samples (with a total of 18 genes for analysis) were harvested from HK-2 cells infected with *L. santarosai* serovar Shermani. In another, the stability value was 0.361 for the best gene target, or LIC12263, which was the most stable gene under our experimental condition from the samples (with a total of 16 genes for analysis) as harvested from HK-2 cells infected with *L. interrogans* serovar Copenhageni.

In the *L. santarosai* serovar Shermani-HK-2 cell infection model, LSS21190 encoding imelysin is downregulated (fold change \<0.5) after infection for 4 h. We show that LSS14677 encoding OmpL37, LSS01089 encoding hypothetical protein, LSS19962 encoding a hypothetical protein with a C39-like domain, LSS16716 encoding FlaB, LSS15341 encoding LipL21 and LSS00320 encoding LipL36 are upregulated (fold change \>2) after infection for 4 h. In addition, the transcripts of LSS08269 encoding a hypothetical protein with an ankyrin repeat involved in function category R (general functional prediction only) and LSS16296 encoding Lsa24 were not detected, most likely reflecting a very low expression level ([Figure 4A](#fig4){ref-type="fig"}).

In *L. interrogans* serovar Copenhageni-HK-2 cell infection model, LIC12676 and LIC10376 encoding hypothetical protein, and LIC12904 encoding a von Willebrand factor A-domain-containing protein are downregulated (fold change \<0.5) after infection for 4 h. The results show that LIC11352 encoding LipL32, LIC13050 encoding a hypothetical protein, LIC11890 encoding FlaB, LIC10011 encoding LipL21, LIC13060 encoding LipL36 and a LIC12339 gene belonging to a paralogous (PF07598) gene family are upregulated (fold change \>2) after infection for 4 h ([Figure 4B](#fig4){ref-type="fig"}). The most interesting result was the dramatic upregulation (almost \>10-fold) of these lipoproteins in *L. interrogans* serovar Copenhageni upon interaction with HK-2 cells.

In this study, lipoprotein gene expression in both *L. santarosai* serovar Shermani and *L. interrogans* serovar Copenhageni were upregulated upon interaction with HK-2 cells in comparison with the culture medium controls alone. Our results indicated that the interaction with human renal proximal tubular cells for 4 h was an important factor in triggering the differential expression of lipoprotein in pathogenic *Leptospira*. spp. It can be hypothesized that lipoprotein is required for attachment only during the early stages of the infection through human renal proximal tubular cells.

DISCUSSION
==========

Here we present the first report of the sequencing and *de novo* assembly of a *Leptospira santarosai* serovar Shermani genome by using a hybrid sequencing strategy in which we combined high-accuracy, short-read data from second-generation sequencing technologies with long-read PacBio data and data interpretation that was performed in a renal tubular cell-based infection model that may elucidate leptospira pathogenesis in kidneys. *L. santarosai* belongs to a less-studied pathogenic species of leptospires. We completed the whole-genome sequences of *L. santarosai* and further compared it with other recently sequenced *Leptospira* spp. genomes. To investigate the virulence factor of *L. santarosai* serovar Shermani and to improve the available genome sequences for comparative analysis, we used *L. santarosai* serovar Shermani (ATCC number 43286) for complete genome sequencing. Because of sequencing biases and high repetitive genomic features of *Leptospira* spp. that make certain regions difficult or impossible to assemble, we combined second-generation sequencing, namely Illumina paired-end, mate-paired sequencing and the 454 GS FLX platform, and third-generation sequencing technology, specifically PacBio RS SMRT DNA sequencing technology. Furthermore, the high-resolution optical mapping platform and Sanger-based manual finishing processes were used to complete the genome sequences. Our hybrid assembly protocol could resolve complex repeat-rich segments of the *Leptospira* spp. genome.

In our previous studies, Illumina sequencing data with shorter reads (\<150 bp) and a De Bruijn graph-based assembler (Velvet and CLC *de novo* assembler) were used for the *de novo* assembly of the draft leptospiral genome sequences, which consisted of a total of 110 contigs. Notwithstanding the announcement of the *Leptospira* genome draft sequence, we are mindful that it contains gaps and nucleotide errors. Moreover, fully sequenced bacterial genomes are superior to draft whole genomes because they provide the only accurate reference for interpreting transcriptomes. To address this issue, we adopted Roche 454 pyrosequencing to generate hundreds of thousands of long reads (\<450 bp). However, our results show that sole reliance on second-generation sequencing technologies cannot usually produce a complete *Leptospira* genome with highly repeated regions greater than 1000 bp in length. Therefore, we then included the PacBio RS sequencing platform, which is a third generation sequencing technology and can produce reads longer than large repeats within the genome. Because PacBio reads are known for their relatively higher error rate, the methods HGAP and AHA were further adopted. Both HGAP and AHA are specifically developed for PacBio reads and can fix potential sequencing error. To validate the quality of this assembly in our study, all raw reads from NGS platforms and all Sanger sequence reads were mapped onto the finished genome sequences, revealing that this assembly genome were covered by these reads, but not all raw reads were mapped onto this assembly genome. In addition, we also designed primers and checked conflict regions (coverage \<20) with Sanger sequencing.

CRISPRs, which are putatively antiviral elements for host defense mechanisms against bacteriophage predation, are a class of repetitive DNA elements that are propagated via horizontal gene transfer in prokaryotes.^[@bib51]^ The CRISPR elements have been detected in *L. santarosai* in addition to *L. interrogans*, but not in *L. borgpetersenii* and *L. biflexa*. The presence of CRISPR elements in the *L. santarosai* genome suggests the presence of genetic alterations and exchanges as a result of bacteriophage infection during evolutionary pressure. In addition, we cannot find putative type II toxin--antitoxin systems that contribute to the stable maintenance and dissemination of plasmids and GIs in *L. santarosai*, suggesting that mobile genetic elements encoding toxin--antitoxin systems are lost during cell division or simply cannot be identified by our annotated method.

Mobile DNA elements including prophages, transposons and insertion sequence elements abound in *Leptospira* spp. A comparative genome analysis in *Leptospira* spp. showed that the number of transposases vary among the species, ranging from 26 in *L. interrogans* and 48 in *L. santarosai* to 241 in *L. borgpetersenii*, suggesting genome plasticity in *Leptospira* species. In addition, a group II intron can be transferred between bacteria on conjugative elements and move from site to site within a bacterium by retrotransposition, and it was previously was identified in *L. borgpetersenii* to provide evidence for lateral transfer in *Leptospira*.^[@bib13]^ Interestingly, unique genes predicted as a group II intron are found in the *L. santarosai* genome. According to this study, we infer that *L. santarosai* unique regions with acquisition through horizontal gene transfer may contain genes specifying virulence traits in addition to genes that may enhance fitness in a specific environmental niche. Moreover, *L. santarosai* and *L. borgpetersenii* genomes are similar in size ([Table 2](#tbl2){ref-type="table"}), but the gene density in *L. santarosai* is much higher, most likely reflecting the greater genetic information required for *L. santarosai* to survive within both mammalian hosts and aquatic environments.

GIs, which provide evidence of lateral gene transfer and contain genes for functions involved in symbiosis or pathogenesis, may introduce virulence factors into a new host genome.^[@bib52]^ Thirteen predicted GIs in *L. santarosai* ranging in sizes above 10 kb were identified by using the online tool IslandViewer (<http://www.pathogenomics.sfu.ca/islandviewer>),^[@bib49]^ which integrates three different GI prediction methods (IslandPick, IslandPath-DIMOB and SIGI-HMM). Of these GIs, there are seven GIs located within unique regions in the *L. santarosai* serovar Shermani genome. In addition, the sequences of a 28 kb gap in the size between scaffolding boards were filled by using PacBio RS information during assembly processes. Interestingly, a unique 28-kb region in *L. santarosai* had been predicted as GI-containing genes that encode transposases, lipoproteins and hypothetical proteins. Furthermore, it revealed the presence of a unique 28-kb region in *L. santarosai* serovar Shermani strain LT821, and in an isolate from a Taiwanese patient called strain CCF, but it is absent in other pathogenic *Leptospira* spp. In this region, LSS19962-encoding hypothetical proteins belonging to a C39-like family were present in *L. santarosai*, but they were absent in other pathogenic *Leptospira* spp. LSS19962. This gene is unique, and it was upregulated in the *L. santarosai* serovar Shermani-HK-2 cell infection model, further suggesting that its functions might be related to adherence or virulence. Genes unique to *L. santarosai* are likely to be necessary for aiding infection (pathogenesis).

Pathogenic *L. santarosai* serovars have been classified into group I pathogens, which cause disease in humans with varying degrees of severity.^[@bib53]^ A chance discovery and experimental evidence showed that virulence-associated genes belonging to a PF07598 gene family present in group I pathogens, but not in group II pathogens and saprophytic species, are highly upregulated during infection relating to kidney colonization. There are two PF07598 paralogs called LSS14871 and LSS03359 that encode hypothetic proteins in the finished whole-genome sequence of *L. santarosai* serovar Shermani LT821.

In this study, the new whole-genome sequence information was useful to develop PCR-based gene markers. A PCR using primers designed on the basis of *L. santarosai* serovar Shermani strain LT821 DNA sequences was used to investigate the presence of these genes in the *L. santarosai* serovar Shermani strain CCF genome sequences, a clinical strain. These results provided evidence of sequence conservation between *L. santarosai* serovar Shermani strain LT821 and strain CCF, in addition to having slight gene number variations. Ideally, the availability of the whole-genome sequence of *L. santarosai* serovar Shermani might have an impact on clinical diagnostic applications.

Next-generation sequencing-based transcriptome responses to *L. santarosai* serovar Shermani strain LT821 infection in HK-2 cells were performed by using sequencing by oligonucleotide ligation and detection technology (data not shown). After aligning RNA-seq reads to the *L. santarosai* serovar Shermani strain LT821 genome, the digital expression levels (RPKM, reads per kilobase of exon model per million mapped reads) of each annotated leptospiral genes were calculated. By using a RPKM value of \>1000, there are 33 leptospiral genes expressed during the cocultivation of *L. santarosai* serovar Shermani strain LT821 with HK-2 cells for a 4 h incubation. However, the PF07598 paralogs LSS14871 and LSS03359 had RPKM values of \<10, indicating that there was lower gene expression under the HK-2 cell-based infection condition. An analysis of RNA-seq data for *L. santarosai* serovar Shermani-infected HK-2 cells revealed 207 transcripts with differential expression (with a fold change of ≥4) between groups at different time points post-infection (2 h vs. 4 h). The complete RNA-seq data will be reported in a separate manuscript that is in preparation. According to data from genome and RNA-seq analysis, species-specific genes and lipoprotein genes were chosen for a comparative analysis of differential leptospiral gene expressions in *L. santarosai* serovar Shermani and *L. interrogans* serovar Copenhageni-infected HK-2 cells. Interestingly, we found that the expression of several lipoprotein genes (e.g., lipL32, 21 and 36) was more upregulated in an *L. interrogans* serovar Copenhageni infection in HK-2 cells than in an *L. santarosai* serovar Shermani strain LT821 infection in HK-2 cells. In addition, our results revealed the transcripts of LSS01089 encoding hypothetical proteins, LSS15341 (for LipL21), LSS00320 (LipL36) and LSS16716 (for FlaB) were upregulated in *L. santarosai* serovar Shermani strain LT821 infection in HK-2 cells, which was consistent with previous information from the transcriptome study. Taken together, we suggest that the interaction with HK-2 cells may be an important factor in triggering the differential expression of major OMPs or lipoproteins in *Leptospira* spp. This finding was in contrast to previous evidence showing that the downregulation of this group of major OMPs or lipoproteins was likely an immune evasion mechanism of *L. interrogans*. In our infection models, this finding supports the hypothesis that OMPs and lipoproteins may be expressed during leptospiral infection and facilitates attachment to the kidney. The overall results derived from the combined computational genome analysis and correlation with the available experimental evidence may be useful in the discovery of novel genes and for understanding the pathogenicity of *Leptospira*.
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![Workflow for the *de novo* assembly of the *L. santarosai* serovar Shermani genome. CI, chromosome I; CII, chromosome II; OM, optical mapping.](emi201478f1){#fig1}

![A circular representation of the *L. santarosai* serovar Shermani genome, with predicted CDSs. (**A**) Chromosome I; (**B**) chromosome II. The inner scale is shown in kb. Circles range from 1 (outer circle) to 6 (inner circle). Circles 1 and 3, genes on forward and reverse strands of CDSs; circles 2 and 4, genes on forward and reverse strands of Clusters of Orthologous Group categories; All genes are color-coded according to their functions: red for lipid transport and metabolism (I), lime for carbohydrate metabolism (G), tan for coenzyme transport and metabolism (H), maroon for translation, ribosomal structure and biogenesis (J), blue for cell motility (N), goldenrod for inorganic ion transport and metabolism (P), cyan for post-translation modification, protein turnover and chaperones (O), plum for signal transduction mechanism (T), yellow for secondary metabolites biosynthesis (Q), green for amino acid transport and metabolism (E), olive for energy production and conversion (C), dark khaki for cell division/chromosome partitioning (D), magenta for nucleotide transport and metabolism (F), indigo for transcription (K), purple for replication, recombination and repair (L), dark cyan for cell wall/membrane/envelope biogenesis (M), dull gray for general function prediction only (R), silver for unknown functions (S); circle 5, GC content; circle 6, GC bias ((G-C)/(G.C). This figure was prepared in CGView.](emi201478f2){#fig2}

![A circular genome map for *L. santarosai* serovar Shermani compared with pathogenic *Leptospira* spp. The sequence similarity detected by BLASTp comparison analysis of chromosome I (**A**) and chromosome II (**B**) of pathogenic *Leptospira* spp. using *L. santarosai* serovar Shermani as a reference were performed with CGView Comparison Tool software. The circles are colored according to the percent identities of matches (black to light red, 100%--50% identity; blue to light blue, 50%--10% identity; and colorless, 0% identity). From the inner to outer circle on **A**: GC skew and GC content of *L. santarosai* serovar Shermani, *L. borgpetersenii* Hardjo-bovis serovar JB197, serovar L550, *L. interrogans* Copenhageni serovar Fiocruz L1-130, *L. interrogans* Lai serovar 56601 and strain IPAV, forward and reverse strand CDSs of *L. santarosai* serovar Shermani. From the inner to outer circle on **B**: GC skew and GC content of *L. santarosai* serovar Shermani, *L. interrogans* Copenhageni serovar Fiocruz L1-130, *L. borgpetersenii* Hardjo-bovis serovar JB197, *L. interrogans* Lai serovar 56601 and strain IPAV, *L. borgpetersenii* Hardjo-bovis serovar L550, forward and reverse strand CDSs of *L. santarosai* serovar Shermani.](emi201478f3){#fig3}

![A comparative analysis of differential leptospiral gene expressions in *L. santarosai* serovar Shermani-infected HK-2 cells (**A**) and *L. interrogans* serovar Copenhageni-infected HK-2 cells (**B**). Data are represented as the means±SD of three independent experiments.](emi201478f4){#fig4}

###### Genome features of *Leptospira* spp.

                              Pathogenic *Leptospira*   Saprophytic *Leptospira*                                                                                                      
  -------------------------- ------------------------- -------------------------- ------------------------ ------------------------ ------------------------ ------------------------ ------------------------------------
  Genomic structures                  CI, CII                   CI, CII                   CI, CII                  CI, CII                  CI, CII                  CI, CII                     CI, CII, p74,
  Size (Mb)                            3.98                       4.63                      4.7                      4.71                     3.93                     3.88                           3.96
  GC (%)                               41.82                       35                        35                       35                      40.2                     40.2                           38.9
  Gene                                 4191                       3762                      3741                     3759                     3273                     3242                           3675
  Coding sequences                     4079                       3667                      3683                     3711                     2945                     2880                           3600
  Ribosomal RNAs                         5                         5                         5                        5                        5                        5                              6
  GenBank accession number      CP006694; CP006695       AE016823.1; AE016824.1    AE010300.2; AE010301.2   CP001221.1; CP001222.1   CP000348.1; CP000349.1   CP000350.1; CP000351.1   CP000777.1; CP000778.1; CP000779.1

Abbreviations: bp, base pair; CI, chromosome I; CII, chromosome II; Mb, mega base pair.

###### Statistics for *de novo* assembly of the *L. santarosai* serovar Shermani strain LT821 (ATCC number 43286) genome.

  Sequencing statistics for the genome mapped reads                                                                                                                                            
  ------------------------------------------------------------------- ---------------------------------- ------------------------- ------------------------- ------------------ -------------- -----------------
  Illumina 2×75 bp paired-end (500 bp[a](#tbfnote2){ref-type="fn"})               7 987 144                 CI: 142X; CII: 143X               75                                               
  Illumina 2×75 bp mate-pair (3000 bp[a](#tbfnote2){ref-type="fn"})               27 550 738                CI: 561X; CII: 548X               100                                              
  Roche 454                                                                        597 201                   CI: 60X; CII: 60X                410                                              
  PacBio (filtered subreads)                                                        40 203                 CI: 4.65X; CII:4.17X              3514                                              
  **Assembly statistics**                                                                                                                                                                      
  **Dataset**                                                          **Number of scaffolds (\>1 kb)**   **Minimun length (bp)**   **Maximun length (bp)**   **Average (bp)**   **N50 (bp)**   **Total bases**
  Illumina (paired-end+mate-pair)                                                     79                           1055                     316 426              49 532.05         101 468         3 972 582
  Roche 454                                                                          243                            101                     81 757               15 956.01          26 460         3 877 310
  PacBio (HGAP)                                                                       13                           8973                    20 75 818             30 9448.2        2 075 818        4 022 826
  Illumina (paired-end+mate-pair)+PacBio (AHA)                                        66                            169                     758 047              60 811.83         366 311         4 013 581
  Roche 454+PacBio (AHA)                                                              41                           1072                     519 368              98 637.02         238 493         4 044 118

Abbreviations: bp, base pair; CI, chromosome I; CII, chromosome II; kb, kilobase.

library size.

###### Unique regions belonging to GIs and containing unique genes in *L. santorosai* serovar Shermani

  Region (bp)             *L. santarosai* locus                                                     Pfam description
  ------------------ -------------------------------- -------------------------------------------------------------------------------------------------------------
  571632--596112      LSS03699; hypothetical protein                                      Protein of unknown function (DUF1018)
                      LSS03734; hypothetical protein                                                       \-
                      LSS03744; hypothetical protein                                                       \-
                      LSS03784; hypothetical protein                                                       \-
                      LSS03789; hypothetical protein                                                       \-
                      LSS03839; hypothetical protein                                                       \-
  901306--925137      LSS16066; hypothetical protein                                         Serine dehydrogenase proteinase
                      LSS16071; hypothetical protein                                                HNH endonuclease
                      LSS16076; hypothetical protein                                                       \-
                      LSS16081; hypothetical protein                                                       \-
                      LSS20376; hypothetical protein                                                       \-
  1241453--1270000    LSS19962; hypothetical protein                                            Peptidase C39-like family
                      LSS20690; hypothetical protein                                      Domain of unknown function (DUF3368)
  1637637--1664268    LSS18234; hypothetical protein                                                       \-
                      LSS18249; hypothetical protein                                                       \-
                      LSS18254; hypothetical protein                                                       \-
                      LSS18259; hypothetical protein                                                       \-
                      LSS18294; hypothetical protein                                                       \-
                      LSS20077; hypothetical protein                                                       \-
  2062735--2081773    LSS09598; hypothetical protein                                                       \-
                      LSS09603; hypothetical protein                                                       \-
                      LSS22020; hypothetical protein         Reverse transcriptase (RNA-dependent DNA polymerase; group II intron, maturase-specific domain
                      LSS22035; hypothetical protein                                                       \-
                      LSS22040; hypothetical protein         Reverse transcriptase (RNA-dependent DNA polymerase); group II intron, maturase-specific domain
  2239208--2254431    LSS16416; hypothetical protein   Aminoglycoside 3-*N*-acetyltransferase; nuclear LIM interactor-interacting factor (NLI-IF)-like phosphatase
                      LSS16441; hypothetical protein                                                       \-
                      LSS22130; hypothetical protein                                       Macrocin-O-methyltransferase (TylF)
  2663206--2678060    LSS15106; hypothetical protein                                                       \-
                      LSS15111; hypothetical protein                                                       \-
                      LSS15146; hypothetical protein                                                       \-
                      LSS15156; hypothetical protein                                                       \-
                      LSS15191; hypothetical protein                                                       \-

###### Genes for leptospiral gene expression analysis in cell-based infection models.

  LSS locus[a](#tbfnote3){ref-type="fn"}          Product          *L. interrogans* Copenhageni homolog[a](#tbfnote3){ref-type="fn"}
  ---------------------------------------- ---------------------- -------------------------------------------------------------------
  LSS19962                                  Hypothetical protein                               Not found
  LSS13769                                  Hypothetical protein                               Not found
  LSS12422                                  Hypothetical protein                               Not found
  LSS12447                                  Hypothetical protein                               Not found
  LSS08624                                  Hypothetical protein                               Not found
  LSS01089                                  Hypothetical protein                               LIC13050
  LSS08269                                  Hypothetical protein                               LIC13236
  LSS02919                                  Hypothetical protein                               LIC12708
  LSS01907                                  Hypothetical protein                               LIC11052
  LSS00500                                  Hypothetical protein                               LIC10376
  LSS03359                                  Hypothetical protein                               LIC12339
  LSS14871                                  Hypothetical protein                               LIC10639
  LSS18953                                         LipL32                                      LIC11352
  LSS15341                                         LipL21                                      LIC10011
  LSS00320                                         LipL36                                      LIC13060
  LSS16716                                          FlaB                                       LIC11890
  LSS16476                                          PseA                                       Not found
  LSS22895                                  Hypothetical protein                               LIC12676
  LSS16296                                         Lsa24                                       LIC12906
  LSS14677                                         OmpL37                                      LIC12263
  LSS21190                                        Imelysin                                     LIC10711

The LSS locus tag corresponds to the *L. santarosai* serovar Shermani genome; the LIC locus tag corresponds to the *L. interrogans* serovar Copenhageni genome.
